Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan

Yau, T; Tai, DV; Chan, SL; Huang, YH; Choo, SP; Hsu, C; Cheung, TT; Lin, SM; Yong, WP; Lee, JYY; Leung, T; Shum, T; Yeung, CSY; Tai, AYP; Law, ALY; Cheng, AL; Chen, LT

Yau, T (通讯作者),Univ Hong Kong, Dept Med, Hong Kong, Peoples R China.

LIVER CANCER, 2022; 11 (5): 426

Abstract

Background: Asia has a high burden of hepatocellular carcinoma (HCC) due to the high rates of chronic hepatitis B infection and accounts for 70% of HC......

Full Text Link